EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Liver Transplantation Outcomes Using Grafts From Brain‐Dead Donors With Warfarin‐Associated Coagulopathy

Behrouz Seydi Majd, Mohammad Mehdi Lashkarizadeh, Alireza Shamsaeefar iD, Saman Nikeghbalian, Hamid Zaferani Arani iD, Sahar Sohrabi Nazari, Seyyed Mohammad Sadegh Ahmadi Rashti, Ahmad Khalid Sanaei, Hamed Nikoupour iD

Journal of Transplantation · 2026-01 · 2026 (1)

DOI: 10.1155/joot/8367205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Transplantation, online erschienen am 30.05.2026. Verfasst von Behrouz Seydi Majd und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Transplant Center, Abu-Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver transplantation is the definitive therapy for end‐stage liver disease. The severe organ shortage necessitates exploring grafts from extended‐criteria donors, including those who become brain dead due to toxicological causes. This study evaluated the outcomes of liver transplantation using grafts from brain‐dead donors with confirmed warfarin‐associated coagulopathy (WAC).

Methods

This retrospective observational cohort study was conducted at a high‐volume transplant center (1994–2024). Ten recipients who received liver grafts from brain‐dead donors with WAC were included. Clinical data were reviewed to assess liver function recovery, complications, and survival.

Results

The cohort included 10 recipients (8 males, 2 females; mean age: 49.8 ± 13.2 years). Liver function tests and international normalized ratio (INR) levels showed significant improvement by Postoperative day 7. Acute rejection occurred in two recipients (20%), successfully treated with corticosteroids. One patient (10%) developed primary nonfunction, leading to death. Patient survival was 100% at 30 days and 70% at 1 year; corresponding graft survival was 90% and 70%.

Conclusion

In this small, highly selected cohort, liver grafts from brain‐dead donors with WAC may be used with acceptable short‐term safety. These preliminary findings demonstrate feasibility and highlight the need for larger, controlled studies to further evaluate outcomes and donor selection criteria.

Schlagwörter

Stichwörter der Autor:innen

brain-dead donorsextended-criteria donorsliver transplantationmarginal donorswarfarin-associated coagulopathy

Autor:innen und Institutionen

  • Shiraz Transplant Center, Abu-Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.

ORCID-Profile: Alireza Shamsaeefar, Hamid Zaferani Arani, Hamed Nikoupour

Zitieren

APA

Majd, B. S., Lashkarizadeh, M. M., Shamsaeefar, A., Nikeghbalian, S., Arani, H. Z., Nazari, S. S., Rashti, S. M. S. A., Sanaei, A. K., & Nikoupour, H. (2026). Evaluation of Liver Transplantation Outcomes Using Grafts From Brain‐Dead Donors With Warfarin‐Associated Coagulopathy. Journal of Transplantation, 2026(1). https://doi.org/10.1155/joot/8367205

Vancouver

Majd BS, Lashkarizadeh MM, Shamsaeefar A, Nikeghbalian S, Arani HZ, Nazari SS, et al. Evaluation of Liver Transplantation Outcomes Using Grafts From Brain‐Dead Donors With Warfarin‐Associated Coagulopathy. Journal of Transplantation. 2026;2026(1). doi:10.1155/joot/8367205

BibTeX
@article{Majd2026,
  author = {Majd, Behrouz Seydi and Lashkarizadeh, Mohammad Mehdi and Shamsaeefar, Alireza and Nikeghbalian, Saman and Arani, Hamid Zaferani and Nazari, Sahar Sohrabi and Rashti, Seyyed Mohammad Sadegh Ahmadi and Sanaei, Ahmad Khalid and Nikoupour, Hamed},
  title = {Evaluation of Liver Transplantation Outcomes Using Grafts From Brain‐Dead Donors With Warfarin‐Associated Coagulopathy},
  journal = {Journal of Transplantation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/joot/8367205}
}
Kostenlos starten →